PHARMA
Cipla Expands Into The US With InvaGen & Exelan Acquistions
Cipla grows its portfolio by acquiring InvaGen and Exelan Pharmaceuticals, stretching its reach to the US market.
Yao Yihong Appointed CBMG CSO
Dr. Yao Yihong has been appointed as CBMG's chief scientific officer to lead research programs in immuno-oncology and autoimmune/inflammatory diseases.
ASLAN’s Bile Duct Cancer Drug Given FDA Orphan Drug Status
ASLAN001 has been awarded orphan drug designation to treat cholangiocarcinoma, a rare and aggressive form of bile duct cancer.
Wuxi & TruTags Tag Team On Drug Tracking
Tracking a drug's provenance and origin just got easier, thanks to edible tags jointly tested by WuXi PharmaTech and TruTags Technology.
Single-Dose Malaria Drug Reaches Human Trials
A long-lasting single-dose malaria drug in phase II clinical trials provides hope for malaria-infected patients.
FDA Approval For Cipla’s Child-Friendly HIV Drug Formulation
A novel pediatric formulation of anti-retroviral drugs could be life saving for children living with HIV.
Roche Diagnostics Strengthens Asia Pacific Footprint
Roche Diagnostics headquarters in Singapore houses state-of-the-art training facilities and technical support services.
Fosun & Guahao.com Partner For Pharma E-Commerce
The cooperation agreement between Fosun Pharmaceuticals and Guahao.com is expected to expand jxdyf.com's pharmaceutical e-commerce platform.
3SBio Acquires Zhejiang Wansheng For US$85 Million
The acquisition of Zhejiang Wansheng expands 3SBio's product offerings in the dialysis, diabetes and dermatology markets.
